Feasibility and Preliminary Outcomes of Area Under the Concentration‐Time Curve ( AUC )‐Guided Tacrolimus and Mycophenolate Dosing in Pediatric Kidney Transplant Recipients
Pediatric Transplantation · 2026
DOI: 10.1111/petr.70274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Song Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada. Hauptthemen laut MEDLINE: Tacrolimus, Mycophenolic Acid, Kidney Transplantation, Immunosuppressive Agents. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
This pilot study evaluated the feasibility of integrating an immunosuppressant area under the concentration‐time curve (AUC) monitoring for tacrolimus and mycophenolic acid (MPA) into pediatric kidney transplantation care.
Methods
Dedicated test codes, an AUC requisition form, and a coordinated laboratory sampling process were established for tacrolimus and MPA AUC. AUC was calculated using the ISBA 3.0 Bayesian pharmacokinetic platform. AUC results were correlated with doses, trough concentrations (C 0 ), 3 h post‐dose concentrations (C 3h ), and clinical outcomes.
Results
The AUC protocol was successfully integrated into the routine clinical workflow. Tacrolimus AUC showed correlations with dose ( r = 0.85) and C 0 ( r = 0.82); similarly, MPA AUC showed correlation with dose ( r = 0.61) and C 3h ( r = 0.65). Of the 21 Tacrolimus AUC measurements, 76% were within the target range, and 24% were below the range. For MPA AUC measurements, 65% (13/20) were within the target range, 5% (1/20) were below the range, and 30% (6/20) were above the range. Following individual AUC measurements, the tacrolimus dose was adjusted after 43% (9/21) of measurements, and the mycophenolate mofetil (MMF) dose was adjusted after 50% (10/20) of measurements.
Conclusion
This AUC pilot study demonstrated the feasibility of integrating AUC‐guided monitoring into the routine management of pediatric kidney transplant recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
- University of Saskatchewan College of Medicine, Saskatoon, Saskatchewan, Canada.
- Department of Pediatric Nephrology, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
- Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Fang Wu
Zitieren
APA
Lu, S., Kakodkar, P., Zhang, D., Mostafa, A., Magee, F., Davis, K., & Wu, F. (2026). Feasibility and Preliminary Outcomes of Area Under the Concentration‐Time Curve ( AUC )‐Guided Tacrolimus and Mycophenolate Dosing in Pediatric Kidney Transplant Recipients. Pediatric Transplantation. https://doi.org/10.1111/petr.70274
Vancouver
Lu S, Kakodkar P, Zhang D, Mostafa A, Magee F, Davis K, et al. Feasibility and Preliminary Outcomes of Area Under the Concentration‐Time Curve ( AUC )‐Guided Tacrolimus and Mycophenolate Dosing in Pediatric Kidney Transplant Recipients. Pediatric Transplantation. 2026. doi:10.1111/petr.70274
BibTeX
@article{Lu2026,
author = {Lu, Song and Kakodkar, Pramath and Zhang, Dan and Mostafa, Ahmed and Magee, Fergall and Davis, Keefe and Wu, Fang},
title = {Feasibility and Preliminary Outcomes of Area Under the Concentration‐Time Curve ( AUC )‐Guided Tacrolimus and Mycophenolate Dosing in Pediatric Kidney Transplant Recipients},
journal = {Pediatric Transplantation},
year = {2026},
doi = {10.1111/petr.70274}
}
EUVIMED